Skip to main content
. 2015 Nov 21;21(43):12249–12260. doi: 10.3748/wjg.v21.i43.12249

Table 1.

Levels of serum and/or urinary bone metabolic markers in patients with disseminated carcinomatosis of the bone marrow associated with gastric cancer

Bone resorption markers
Bone formation markers
Age Sex 1CTP (4.5 mg/mL)2 NTx (urine) (< 89 nmol/L BCE/mmol/L Cre)2 DPD (urine) (< 7.6 nmol/L BCE/mmol/L Cre)2 BAP (< 20.9 μg/L)2 OC (< 13.0 ng/mL)2
Case report
Takeda et al[10] 87 F - 14800 59 929 32
Hasuda et al[11] 39 M 19.5 - - - -
Mizuno et al[12] 44 M - - 59 - 37
Our cases1
1 60 M 8.9 - - 258 -
2 47 F 17.7 > 300 - 1260 -
3 74 F 8.0 - - 78 -
4 54 M 9.7 - - 55 -
5 58 M 6.7 - - 96 -
6 47 F - - - 275 -
7 58 M 13.2 - - 159 -
8 78 F 26.5 > 300 - 429 -
9 67 F 6.7 175 - 63 -
10 71 M 14.4 > 300 - 421 -
11 53 F 9.9 235 - 468 -
12 70 M - 20 - 62 -
1

Our 12 cases have not been published;

2

Values in the parentheses indicate the normal range. 1CTP: C-terminal telopeptide of type I collagen; NTx: N-terminal crosslinking telopeptide of type I collagen; DPD: Deoxypyridinoline; BAP: Bone-specific alkaline phosphatase; OC: Osteocalcin.